BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24292163)

  • 1. Inflammation and pancreatic cancer: disease promoter and new therapeutic target.
    Hamada S; Masamune A; Shimosegawa T
    J Gastroenterol; 2014 Apr; 49(4):605-17. PubMed ID: 24292163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer and its stroma: a conspiracy theory.
    Xu Z; Pothula SP; Wilson JS; Apte MV
    World J Gastroenterol; 2014 Aug; 20(32):11216-29. PubMed ID: 25170206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
    Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
    Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A starring role for stellate cells in the pancreatic cancer microenvironment.
    Apte MV; Wilson JS; Lugea A; Pandol SJ
    Gastroenterology; 2013 Jun; 144(6):1210-9. PubMed ID: 23622130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.
    Birtolo C; Go VL; Ptasznik A; Eibl G; Pandol SJ
    Pancreas; 2016 Jan; 45(1):21-31. PubMed ID: 26658038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role of pancreatic stellate cells in pancreatic cancer.
    Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
    Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic stellate cell: Pandora's box for pancreatic disease biology.
    Bynigeri RR; Jakkampudi A; Jangala R; Subramanyam C; Sasikala M; Rao GV; Reddy DN; Talukdar R
    World J Gastroenterol; 2017 Jan; 23(3):382-405. PubMed ID: 28210075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.
    Lonardo E; Frias-Aldeguer J; Hermann PC; Heeschen C
    Cell Cycle; 2012 Apr; 11(7):1282-90. PubMed ID: 22421149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
    Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
    Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer.
    Kemp SB; Pasca di Magliano M; Crawford HC
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1531-1542. PubMed ID: 34303882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.
    Apte MV; Wilson JS
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():69-74. PubMed ID: 22320920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex role for the immune system in initiation and progression of pancreatic cancer.
    Inman KS; Francis AA; Murray NR
    World J Gastroenterol; 2014 Aug; 20(32):11160-81. PubMed ID: 25170202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the role of stroma in pancreatic cancer.
    Waghray M; Yalamanchili M; di Magliano MP; Simeone DM
    Curr Opin Gastroenterol; 2013 Sep; 29(5):537-43. PubMed ID: 23892539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pancreatitis: a path to pancreatic cancer.
    Pinho AV; Chantrill L; Rooman I
    Cancer Lett; 2014 Apr; 345(2):203-9. PubMed ID: 23981573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research.
    Pang TCY; Xu Z; Pothula S; Becker T; Goldstein D; Pirola RC; Wilson JS; Apte MV
    Carcinogenesis; 2017 Jun; 38(6):588-591. PubMed ID: 28379317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
    Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
    Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model.
    Yoshida M; Miyasaka Y; Ohuchida K; Okumura T; Zheng B; Torata N; Fujita H; Nabae T; Manabe T; Shimamoto M; Ohtsuka T; Mizumoto K; Nakamura M
    Cancer Sci; 2016 Oct; 107(10):1443-1452. PubMed ID: 27487486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.